omniture
Ascletis BioScience Co.,Ltd./歌礼生物科技(杭州)有限公司

Latest News

Ascletis Opens Clinical Development Shanghai Center

HANGZHOU and SHAOXING, China, Aug. 12, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an inno...

2019-08-12 18:00 1134

Ascletis Received IND Approval and Management Outlook of 2019 and Beyond

HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innov...

2019-08-05 08:00 2025

3-V Biosciences Commences Dosing in Phase 2 Clinical Study of the FASN Inhibitor TVB-2640 in Patients with NASH

SAN MATEO, Calif. and HANGZHOU and SHAOXING, China, May 1, 2019 /PRNewswire/ -- 3-V Biosciences, In...

2019-05-01 06:00 5354

Ganovo is Eligible for the Basic Medical Insurance of Zhejiang Province - Reimbursement-by-disease

HANGZHOU and SHAOXING, China, April 15, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, 1672.H...

2019-04-15 17:12 3094

Ascletis Appoints Former MSD Global Vice President Dr. Zhengqing Li as Chief Medical Officer and President of R&D Greater China

HANGZHOU, China and SHAOXING, China, March 1, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), ...

2019-03-01 08:00 1397

Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing

HANGZHOU and SHAOXING, China and SAN FRANCISCO, Feb. 13, 2019 /PRNewswire/ -- Ascletis Pharma Inc. ...

2019-02-13 08:00 1135

Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases

HANGZHOU, China and SHAOXING, China and SUZHOU, China, Jan. 14, 2019 /PRNewswire/ -- Ascletis Pharm...

2019-01-14 08:30 1064

Ascletis' IND Filing for Its Third HCV Drug ASC21 Accepted by NMPA

HANGZHOU and SHAOXING, China, Jan. 3, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), a commer...

2019-01-03 08:00 1458

Ascletis' Ganovo Enrolled in the Basic Medical Insurance of Chengdu

HANGZHOU, China and SHAOXING, China, Jan. 2, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), a...

2019-01-02 08:00 1291

Ascletis and Roche enter exclusive Pegasys partnership in China for viral Hepatitis

SHANGHAI, HANGZHOU and SHAOXING, China, Nov. 20, 2018 /PRNewswire/ -- Shanghai Roche Pharmaceutical...

2018-11-20 18:30 829

Ascletis Appoints Dr. Lindi Tan as Chief Financial Officer

HANGZHOU and SHAOXING, China, Nov. 11, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) , a comm...

2018-11-12 07:30 936

Ascletis to Present Phase II / III Clinical Study for Its All-oral HCV Treatment at the 69th Annual meeting of AASLD

HANGZHOU, China and SHAOXING, China, Nov. 6, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), a...

2018-11-06 08:00 790

Ascletis' Ravidasvir NDA Proposed for Priority Review by the CFDA

HANGZHOU and SHAOXING, China, Oct. 18, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) announce...

2018-10-18 16:30 866

Ascletis' Ganovo is Eligible for Shaoxing Government Funding Subsidy Program to Treat HCV Patients

HANGZHOU, China and SHAOXING, China, Oct. 15, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) a...

2018-10-15 16:30 831

Ganovo Enrolled in the Basic Medical Insurance of Tianjin--Capped Reimbursement-Per-Patient Pilot Program

HANGZHOU and SHAOXING, China, Sept. 26, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) announc...

2018-09-26 06:30 761

Ascletis Appoints Mr. Joshua Zhongbao Ling as VP Finance

HANGZHOU, China and SHAOXING, China, Aug. 30, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) a...

2018-08-30 16:40 1371

Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA

HANGZHOU, China and SHAOXING, China, Aug. 1, 2018 /PRNewswire/ -- Ascletis announced today it has r...

2018-08-01 18:52 487

Ascletis Filed NDA for Its All-oral HCV Treatment

HANGZHOU and SHAOXING, China, July 31, 2018 /PRNewswire/ -- Ascletis announced today that it has fi...

2018-07-31 20:43 874

Ganovo (R) Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association

HANGZHOU and SHAOXING, China, July 30, 2018 /PRNewswire/ -- Ascletis announced today the Ganovo® ph...

2018-07-30 17:42 855

Ascletis and CR Pharmaceutical Commercial Group Co., Ltd. Signed Strategic Cooperation Agreement

BEIJING, June 26, 2018 /PRNewswire/ -- Ascletis BioScience Co., Ltd.("Ascletis") and CR Pharmaceuti...

2018-06-26 16:39 855
12